Neuralstem Investigator Presents New Als Nsi-566 Data at International Symposium on Als/MND

Neuralstem, Inc. announced that Jonathon Glass, MD, Director of the Emory ALS Center, presented new data from the Phase I trial of Neuralstem's human spinal cord stem cells, NSI-566, in amyotrophic lateral sclerosis at the International Symposium on ALS/MND in Chicago, sponsored by the Motor Neurone Disease Association.

http://www.drugs.com/clinical_trials/neuralstem-investigator-presents-new-als-nsi-566-data-international-symposium-als-mnd-14828.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+Drugscom-ClinicalTrials+%28Drugs.com+-+Clinical+Trials%29